Taimei Technology

About:

Taimei Technology provides a cloud platform for clinical research collaboration.

Website: http://www.taimei.com

Top Investors: Tencent, Tiger Global Management, Matrix Partners China, Northern Light Venture Capital, SAIF Partners

Description:

Taimei Technology is a Digital Innovator in the R&D and Life Science Industry. Taimei has developed an industry-leading, successfully deployed integrated digital platform that is dedicated to clinical research with in-depth insights into drug R&D, pharmacovigilance, marketing & sales and market access. Our unified digital platform integrates advanced AI, big data, cloud computing and mobile Internet technologies to provide innovative solutions to the industry stakeholders across the full product life cycle. Taimei Technology is building the infrastructure for the future of the life science industry to accelerate product launches, improve quality, enhance drug safety, improve drug accessibility and reduce the medical burden on patients and providers.

Total Funding Amount:

$530M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Jiaxing, Zhejiang, China

Founded Date:

2013-06-06

Contact Email:

marketing(AT)itaimei.com

Founders:

Lu Zhao

Number of Employees:

501-1000

Last Funding Date:

2020-09-28

IPO Status:

Public

© 2025 bioDAO.ai